Related Experiment Video
Updated: Aug 12, 2026
10:56
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Familial hypercholesterolemia: genetic predisposition to atherosclerosis
1Department of Physiological Nursing, School of Nursing, University of California, San Francisco, CA, USA.
Medsurg Nursing : Official Journal of the Academy of Medical-Surgical Nurses
|September 24, 2004
Summary
Familial hypercholesterolemia, a common genetic disorder, leads to high LDL cholesterol due to faulty LDL receptors. This significantly increases the risk of early-onset atherosclerosis and cardiovascular disease.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Metabolic Disorders
Background:
- Familial hypercholesterolemia (FH) is a prevalent inherited condition.
- It is characterized by significantly elevated plasma low-density lipoprotein (LDL) cholesterol levels from birth.
- This elevation is primarily caused by genetic defects affecting the LDL receptor pathway.
Purpose of the Study:
- To elucidate the genetic basis of familial hypercholesterolemia.
- To understand the pathophysiological mechanisms linking FH to cardiovascular disease.
- To highlight the clinical implications of diminished LDL receptor function.
Main Methods:
- Genetic analysis to identify mutations in genes related to LDL metabolism.
- Biochemical assays to measure plasma lipid profiles, particularly LDL cholesterol.
- Clinical assessment for early signs of atherosclerosis and cardiovascular events.
Main Results:
- Confirmed FH as a frequent genetic disorder.
- Demonstrated a direct correlation between reduced LDL receptor activity and hypercholesterolemia.
- Identified premature atherosclerosis and cardiovascular disease as major consequences.
Conclusions:
- Familial hypercholesterolemia necessitates early diagnosis and management.
- Understanding LDL receptor dysfunction is crucial for preventing cardiovascular complications.
- Genetic screening can identify at-risk individuals for timely intervention.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...